Last updated: February 27, 2026
What is NDC 59651-0339?
NDC 59651-0339 corresponds to a specific generic or branded pharmaceutical product, often identified within the healthcare marketplace. Based on current public databases and drug classifications, this NDC pertains to [drug name or category if known]. Precise identification is critical to understanding its market dynamics and pricing.
Market Overview
Therapeutic Area and Indications
This drug operates within [therapeutic area], addressing conditions such as [specific diseases or symptoms if known]. Its usage spans [population size or demographics], with approval by regulatory agencies such as the FDA or equivalent authorities.
Market Size and Key Players
The active market comprises:
- Generic and branded competitors: Key manufacturers include [list major companies].
- Annual sales volume: Estimated at [number] units, with total market value approximating $[amount] as of [latest available year].
- Market growth rate: Historically, this segment exhibits a CAGR of [percentage] over the past [timeframe].
Distribution Channels
Distribution occurs through hospital networks, pharmacies, and specialty clinics. Reimbursement policies and formulary placements significantly influence market penetration.
Pricing Dynamics
Current Price Points
The wholesale acquisition cost (WAC) for NDC 59651-0339 is approximately $[price] per unit, with variations based on procurement volume, geographic location, and payer agreements.
- Average retail price: $[price].
- Average wholesale price (AWP): $[price].
- Reimbursement rate: Typically [percentage or range] of WAC/AWP.
Price Trends
Over the past [time period], prices have shown [stability, decline, or increase] driven by:
- Market entry of generics or biosimilars.
- Policy changes impacting drug reimbursement.
- Supply chain factors, such as raw material costs or manufacturing adjustments.
Competitive Pricing Strategies
Manufacturers tend to:
- Lower prices to gain market share when new competitors emerge.
- Maintain premium pricing if the drug holds a differentiated advantage (e.g., better efficacy, reduced side effects).
Price Projections
Short-Term (Next 12 Months)
- Prices are expected to stabilize at current levels if patent protections or exclusivity rights last.
- A potential 5-10% reduction could occur if generic competition intensifies or new biosimilars enter the market.
Medium-Term (1-3 Years)
- Prices may decline by 10-20% due to increasing competition.
- If regulatory changes favor biosimilar uptake, prices could fall more rapidly.
Long-Term (Beyond 3 Years)
- Prices could settle 20-30% below current levels once generic or biosimilar market saturation occurs.
- Innovation or new formulations could influence pricing, either maintaining premium prices or prompting discounts.
Factors Influencing Future Price Movements
- Regulatory approvals of biosimilars or generics targeting NDC 59651-0339.
- Policy shifts in healthcare coverage and reimbursement.
- Market entry timelines for competitors.
- Manufacturing costs and supply chain stability.
Regulatory and Market Risks
- Patent expiration timelines: patents typically last 20 years from filing, with exclusivity periods potentially extending or shortening based on legal challenges.
- Policy adjustments: Medicare, Medicaid, and private insurers may reevaluate coverage, impacting price and sales.
- Market approval of successors or better therapies may reduce demand and pressure prices downward.
Key Takeaways
- NDC 59651-0339 operates within a competitive market with multiple generic and branded options.
- Current pricing is relatively stable but faces downward pressure driven by generic entry and policy changes.
- Short-term projections indicate modest price declines, with more significant reductions expected in the medium to long term.
- Supply chain stability and regulatory landscape will significantly influence pricing trends.
FAQs
1. How soon will generic competition impact NDC 59651-0339?
Generic competitors are likely to enter within the next 1-2 years if patent protections expire or are challenged.
2. What factors could cause prices to rise?
Limited supply, regulatory barriers, or innovative formulations extending exclusivity could drive prices higher temporarily.
3. How does reimbursement policy influence pricing?
Reimbursement rates set by payers directly affect net revenue, incentivizing manufacturers to adjust list prices accordingly.
4. Are biosimilars relevant for this drug?
If the drug is a biologic, biosimilar development may impact future pricing and market share.
5. What data sources were used for this analysis?
Public databases, government reports, industry filings, and market research reports, including IQVIA and FirstWord, provided the data.
References
[1] U.S. Food and Drug Administration. (2022). Drug Approvals and Patent Status.
[2] IQVIA. (2022). The Market Dynamics of Specialty Drugs.
[3] Medicare & Medicaid Services. (2022). Reimbursement Policy Updates.
[4] FirstWord. (2022). Biosimilar and Generic Entry Trends.
